Respiratory Infections, Acute Completed Phase 3 Trials for Ingavirin (DB11944)

Also known as: Acute Respiratory Infections (ARIs) / Acute Infection Respiratory / Acute Respiratory Infections / Acute Respiratory Infection

IndicationStatusPhase
DBCOND0031056 (Respiratory Infections, Acute)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03189537Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral InfectionsPrevention
NCT03191097Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.Treatment
NCT03206346Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients 13-17 y.o.Treatment